Globe Life (NYSE:GL) Releases FY 2026 Earnings Guidance

Globe Life (NYSE:GL) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 15.550-15.950 for the period, compared to the consensus earnings per share estimate of 15.650. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

Several research firms recently weighed in on GL. JPMorgan Chase & Co. lifted their price objective on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research note on Tuesday. Truist Financial increased their target price on shares of Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Friday, April 24th. Keefe, Bruyette & Woods lifted their price target on shares of Globe Life from $180.00 to $192.00 and gave the stock an “outperform” rating in a research report on Monday, July 13th. TD Cowen boosted their price target on shares of Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday. Finally, Morgan Stanley upped their price objective on shares of Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research report on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $187.60.

Globe Life Price Performance

NYSE GL opened at $170.65 on Friday. The firm’s 50 day moving average is $168.70 and its 200-day moving average is $152.76. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life has a 12-month low of $123.00 and a 12-month high of $191.55. The company has a market capitalization of $13.25 billion, a PE ratio of 11.33 and a beta of 0.47.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The business had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the prior year, the company earned $3.05 earnings per share. The company’s quarterly revenue was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities research analysts anticipate that Globe Life will post 15.64 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Monday, July 6th. Globe Life’s payout ratio is presently 9.13%.

Insider Activity

In other news, CEO Frank M. Svoboda sold 10,000 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the transaction, the chief executive officer directly owned 54,020 shares in the company, valued at $9,004,053.60. The trade was a 15.62% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO James Matthew Darden sold 4,663 shares of the firm’s stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total transaction of $717,542.44. Following the completion of the sale, the chief executive officer owned 58,451 shares of the company’s stock, valued at $8,994,439.88. This trade represents a 7.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 90,187 shares of company stock valued at $14,299,874. 2.11% of the stock is owned by insiders.

Globe Life News Roundup

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life reported higher second-quarter profit and net operating income of $3.61 per share versus $3.27 a year ago, supported by strong underwriting income and broad revenue gains. Insurer Globe Life’s second-quarter profit rises on strong underwriting income
• Positive Sentiment: The company raised its FY 2026 EPS guidance to $15.55-$15.95 and also increased planned share repurchases to $670M-$700M, which signals management confidence in future cash generation. Globe Life projects 2026 net operating EPS of $15.55-$15.95 while lifting share repurchases to
• Positive Sentiment: Analysts at TD Cowen and JPMorgan reportedly turned constructive, with TD Cowen raising its price target and JPMorgan saying the stock should rise, reinforcing a bullish longer-term view. TD Cowen Forecasts Strong Price Appreciation for Globe Life (NYSE:GL) Stock
• Neutral Sentiment: Revenue came in roughly in line with estimates at $1.60 billion, suggesting the quarter was operationally steady despite investor disappointment over sales momentum.
• Negative Sentiment: Quarterly EPS of $3.61 missed the $3.67 consensus, and several headlines pointed to escalating expenses and sales that did not excite investors, which likely pressured the stock. Globe Life Q2 earnings beat isn’t enough: Shares fall 7% as soft sales disappoint

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in GL. CYBER HORNET ETFs LLC acquired a new stake in Globe Life during the 2nd quarter valued at $28,000. MUFG Securities EMEA plc bought a new position in shares of Globe Life in the second quarter valued at about $31,000. Banque Cantonale Vaudoise acquired a new stake in shares of Globe Life during the 3rd quarter worth about $50,000. Summit Securities Group LLC boosted its holdings in shares of Globe Life by 203.6% during the 4th quarter. Summit Securities Group LLC now owns 422 shares of the company’s stock worth $59,000 after buying an additional 283 shares during the period. Finally, Brown Brothers Harriman & Co. boosted its holdings in shares of Globe Life by 105.6% during the 4th quarter. Brown Brothers Harriman & Co. now owns 477 shares of the company’s stock worth $67,000 after buying an additional 245 shares during the period. 81.61% of the stock is currently owned by institutional investors.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.